HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Typhoid fever in Singapore: a review of 370 cases.

Abstract
The medical records of 370 patients treated for typhoid fever between 1986 and 1988 at the Communicable Disease Centre, Singapore, were reviewed. The disease was generally mild. There was no mortality. Fever was found in 98.4% of patients on admission and diarrhoea in 21%. Cough was predominantly a symptom of children and occurred in 7.1% of patients aged below 15 years. Other symptoms were uncommon. Hepatomegaly was found in 71% and splenomegaly in 47%. Leucopenia was not a helpful diagnostic marker. Chloramphenicol was the drug of choice. The relapse rate was 5.4% and the convalescent and temporary carrier rates 11.6%. The risk of developing the carrier state was significantly higher among patients who were afebrile on admission compared with those who were febrile (P less than 0.001); it was also higher in patients treated with ampicillin as compared to those treated with chloramphenicol (P less than 0.001, chi 2 = 22.7, odds ratio = 5.25, 95% confidence limits: 2.46 and 11.29). The role of ampicillin as a first line treatment for acute typhoid fever may need further re-evaluation.
AuthorsF S Yew, S K Chew, K T Goh, E H Monteiro, Y S Lim
JournalThe Journal of tropical medicine and hygiene (J Trop Med Hyg) Vol. 94 Issue 5 Pg. 352-7 (Oct 1991) ISSN: 0022-5304 [Print] England
PMID1942216 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Anti-Bacterial Agents (therapeutic use)
  • Carrier State (drug therapy, epidemiology)
  • Child
  • Child, Preschool
  • Diarrhea (epidemiology)
  • Ethnicity
  • Female
  • Fever (epidemiology)
  • Hepatomegaly (epidemiology)
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Sex Factors
  • Singapore (epidemiology)
  • Splenomegaly (epidemiology)
  • Typhoid Fever (drug therapy, epidemiology)
  • Vomiting (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: